Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Photo Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115057794B enables visible light-induced demethylation. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Novel NHC catalyzed visible light synthesis method offers green efficient production for pharmaceutical intermediates supply chain.
Novel Ni-catalyzed photochemical synthesis offers cost reduction and high enantioselectivity for pharmaceutical intermediates manufacturing.
Patent CN110698313B details a novel Ru-catalyzed route for (Z)-4-trifluoromethyl-5-sulfanyl-4-pentenone derivatives, offering mild conditions and high stereoselectivity for pharma intermediates.
Patent CN118239888A reveals a light-induced modular synthesis for high-purity acridine compounds, offering significant cost reduction and supply chain reliability for photocatalyst manufacturing.
Patent CN104003828B details a copper complex catalyzed coupling reaction under visible light, offering cost reduction in fine chemical manufacturing and high-purity intermediates.
Patent CN108586283B reveals a green visible-light method using Rose Bengal, eliminating metal oxidants for safer pharmaceutical intermediate manufacturing.
Patent CN119431386A reveals photocatalytic synthesis enabling cost reduction in pharmaceutical intermediates manufacturing with high purity and scalable green chemistry processes.
Visible light photocatalysis method for beta-methoxy fatty acid esters. Metal-free, green process offering supply chain stability and cost efficiency for fine chemical manufacturing.
Patent CN113582873B reveals a green photocatalytic route for N-benzyl enamine using flavin catalysts. Discover cost-effective, scalable manufacturing solutions.
Novel Fe-catalyzed photochemical route for benzamide. Reduces cost and improves selectivity for pharmaceutical intermediates.
Patent CN115611713B reveals a blue light synthesis method for fluorenol derivatives, offering cost reduction and high purity for electronic chemical supply chains.
Patent CN115043787B reveals metal-free photocatalytic route. Offers significant cost reduction and supply chain reliability for high-purity oxazole intermediate manufacturing globally.
Patent CN111269228A reveals a green photocatalytic route for fluorescent indolizine derivatives, offering cost-effective manufacturing for pharma intermediates.
Novel visible-light method for quinoline intermediates. Reduces cost and improves supply chain reliability for anti-tumor drug development.
Patent CN111777477A details a mild visible-light method for synthesizing succinic acid derivatives and 3-arylpropionic acids using CO2, offering significant cost and safety advantages.
Patent CN108083999B details a visible-light catalyzed route for alpha-hydroxy ketones, offering cost reduction and green manufacturing advantages for pharmaceutical intermediates.
Patent CN117362209B reveals green photocatalytic synthesis for N-dimercaptobenzamide derivatives offering cost reduction and supply chain reliability.
Patent CN115745836A reveals a blue-light mediated method for C-C bond cleavage, offering cost-effective routes for high-purity pharmaceutical intermediates and functional materials.
Patent CN112812040B details a visible-light mediated route to high-purity guanylhydrazone derivatives, offering significant cost reduction in organic synthesis manufacturing.